Revvity (NYSE:RVTY) Price Target Cut to $100.00 by Analysts at JPMorgan Chase & Co.

Revvity (NYSE:RVTY - Free Report) had its target price decreased by JPMorgan Chase & Co. from $120.00 to $100.00 in a research report released on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

A number of other research firms have also recently commented on RVTY. Robert W. Baird lowered their price target on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Barclays lowered their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. KeyCorp raised their target price on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Sanford C. Bernstein downgraded shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Finally, Raymond James reissued an "outperform" rating and set a $120.00 price objective (down previously from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Price Performance

Shares of NYSE RVTY traded up $1.14 during mid-day trading on Tuesday, reaching $94.04. The company had a trading volume of 944,884 shares, compared to its average volume of 931,013. The firm has a market cap of $11.30 billion, a price-to-earnings ratio of 42.55, a PEG ratio of 3.82 and a beta of 1.07. The business's 50-day simple moving average is $102.80 and its 200 day simple moving average is $112.07. Revvity has a one year low of $88.53 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60.

Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The business's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.98 EPS. On average, research analysts predict that Revvity will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be issued a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.30%. Revvity's payout ratio is 11.91%.

Institutional Investors Weigh In On Revvity

Several large investors have recently added to or reduced their stakes in RVTY. Nissay Asset Management Corp Japan ADV grew its position in Revvity by 0.6% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company's stock valued at $1,682,000 after purchasing an additional 91 shares during the period. Quarry LP grew its holdings in shares of Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after buying an additional 95 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Revvity by 2.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company's stock worth $470,000 after acquiring an additional 100 shares in the last quarter. HB Wealth Management LLC raised its holdings in shares of Revvity by 4.6% in the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock worth $266,000 after acquiring an additional 104 shares during the last quarter. Finally, Signaturefd LLC lifted its position in Revvity by 6.8% in the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock valued at $186,000 after acquiring an additional 106 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.